Pharmacyte Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.74

+0.04 (+5.89%)

As of Feb 8, 2:30 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,641.2% upside

Low Target $20.43

Average Target $27.73

High Target $35.07

Current Price $0.74

Current
$0.74

Target
$27.73

$20.43 $27.73 avg $35.07

Scenario Analysis

Bear Case

$20.43

2,656.3%

Low target

Base Case

$27.73

+3,641.2%

Avg target

Bull Case

$35.07

+4,631.5%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$31.42

-97.6% from high

52-Week Low

$16.93

+-95.6% from low

Target vs 52W High

$27.73

-11.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%